KAMADA LTD (KMDA) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:KMDA • IL0010941198

7.98 USD
-0.12 (-1.48%)
Last: Feb 5, 2026, 03:31 PM
Fundamental Rating

6

Overall KMDA gets a fundamental rating of 6 out of 10. We evaluated KMDA against 524 industry peers in the Biotechnology industry. KMDA has an excellent profitability rating, but there are some minor concerns on its financial health. KMDA may be a bit undervalued, certainly considering the very reasonable score on growth These ratings could make KMDA a good candidate for value investing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • In the past year KMDA was profitable.
  • In the past year KMDA had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: KMDA reported negative net income in multiple years.
  • KMDA had a positive operating cash flow in 4 of the past 5 years.
KMDA Yearly Net Income VS EBIT VS OCF VS FCFKMDA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

1.2 Ratios

  • KMDA has a Return On Assets of 5.42%. This is amongst the best in the industry. KMDA outperforms 91.98% of its industry peers.
  • KMDA has a better Return On Equity (7.72%) than 91.60% of its industry peers.
  • The Return On Invested Capital of KMDA (6.67%) is better than 93.13% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for KMDA is significantly below the industry average of 18.09%.
  • The last Return On Invested Capital (6.67%) for KMDA is above the 3 year average (2.97%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 5.42%
ROE 7.72%
ROIC 6.67%
ROA(3y)1.79%
ROA(5y)2.56%
ROE(3y)2.5%
ROE(5y)3.16%
ROIC(3y)2.97%
ROIC(5y)N/A
KMDA Yearly ROA, ROE, ROICKMDA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10 15

1.3 Margins

  • KMDA's Profit Margin of 11.70% is amongst the best of the industry. KMDA outperforms 91.79% of its industry peers.
  • In the last couple of years the Profit Margin of KMDA has declined.
  • KMDA has a better Operating Margin (15.89%) than 93.70% of its industry peers.
  • KMDA's Operating Margin has declined in the last couple of years.
  • KMDA has a better Gross Margin (43.75%) than 74.43% of its industry peers.
  • In the last couple of years the Gross Margin of KMDA has grown nicely.
Industry RankSector Rank
OM 15.89%
PM (TTM) 11.7%
GM 43.75%
OM growth 3YN/A
OM growth 5Y-7.07%
PM growth 3YN/A
PM growth 5Y-13.08%
GM growth 3Y14.12%
GM growth 5Y2.16%
KMDA Yearly Profit, Operating, Gross MarginsKMDA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so KMDA is destroying value.
  • Compared to 1 year ago, KMDA has more shares outstanding
  • The number of shares outstanding for KMDA has been increased compared to 5 years ago.
  • KMDA has a worse debt/assets ratio than last year.
KMDA Yearly Shares OutstandingKMDA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
KMDA Yearly Total Debt VS Total AssetsKMDA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

  • An Altman-Z score of 3.62 indicates that KMDA is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 3.62, KMDA is in the better half of the industry, outperforming 70.42% of the companies in the same industry.
  • The Debt to FCF ratio of KMDA is 0.59, which is an excellent value as it means it would take KMDA, only 0.59 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 0.59, KMDA belongs to the top of the industry, outperforming 95.04% of the companies in the same industry.
  • KMDA has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
  • KMDA's Debt to Equity ratio of 0.04 is in line compared to the rest of the industry. KMDA outperforms 42.56% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.59
Altman-Z 3.62
ROIC/WACC0.77
WACC8.65%
KMDA Yearly LT Debt VS Equity VS FCFKMDA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M 250M

2.3 Liquidity

  • KMDA has a Current Ratio of 4.02. This indicates that KMDA is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 4.02, KMDA is in line with its industry, outperforming 48.09% of the companies in the same industry.
  • KMDA has a Quick Ratio of 2.25. This indicates that KMDA is financially healthy and has no problem in meeting its short term obligations.
  • KMDA's Quick ratio of 2.25 is on the low side compared to the rest of the industry. KMDA is outperformed by 70.61% of its industry peers.
Industry RankSector Rank
Current Ratio 4.02
Quick Ratio 2.25
KMDA Yearly Current Assets VS Current LiabilitesKMDA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 28.57% over the past year.
  • The earnings per share for KMDA have been decreasing by -13.60% on average. This is quite bad
  • KMDA shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.36%.
  • The Revenue has been growing slightly by 4.82% on average over the past years.
EPS 1Y (TTM)28.57%
EPS 3YN/A
EPS 5Y-13.6%
EPS Q2Q%28.57%
Revenue 1Y (TTM)10.36%
Revenue growth 3Y15.82%
Revenue growth 5Y4.82%
Sales Q2Q%12.63%

3.2 Future

  • KMDA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.48% yearly.
  • Based on estimates for the next years, KMDA will show a quite strong growth in Revenue. The Revenue will grow by 10.57% on average per year.
EPS Next Y44.17%
EPS Next 2Y33.36%
EPS Next 3Y29.48%
EPS Next 5YN/A
Revenue Next Year12.37%
Revenue Next 2Y11.88%
Revenue Next 3Y10.57%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
KMDA Yearly Revenue VS EstimatesKMDA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M
KMDA Yearly EPS VS EstimatesKMDA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4 -0.4

More info and screens

Find the best growth stocksShow best growing peers

7

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 22.17, which indicates a rather expensive current valuation of KMDA.
  • Based on the Price/Earnings ratio, KMDA is valued cheaply inside the industry as 94.27% of the companies are valued more expensively.
  • KMDA is valuated rather cheaply when we compare the Price/Earnings ratio to 28.25, which is the current average of the S&P500 Index.
  • A Price/Forward Earnings ratio of 17.26 indicates a rather expensive valuation of KMDA.
  • Based on the Price/Forward Earnings ratio, KMDA is valued cheaper than 94.66% of the companies in the same industry.
  • KMDA's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.50.
Industry RankSector Rank
PE 22.17
Fwd PE 17.26
KMDA Price Earnings VS Forward Price EarningsKMDA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • KMDA's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. KMDA is cheaper than 97.52% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, KMDA is valued cheaper than 94.47% of the companies in the same industry.
Industry RankSector Rank
P/FCF 24.55
EV/EBITDA 9.44
KMDA Per share dataKMDA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

  • KMDA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • KMDA has a very decent profitability rating, which may justify a higher PE ratio.
  • KMDA's earnings are expected to grow with 29.48% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.5
PEG (5Y)N/A
EPS Next 2Y33.36%
EPS Next 3Y29.48%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. Dividend

5.1 Amount

  • KMDA has a Yearly Dividend Yield of 2.40%.
  • Compared to an average industry Dividend Yield of 1.12, KMDA pays a better dividend. On top of this KMDA pays more dividend than 98.66% of the companies listed in the same industry.
  • KMDA's Dividend Yield is a higher than the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 2.4%

5.2 History

  • KMDA is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
KMDA Yearly Dividends per shareKMDA Yearly Dividends per shareYearly Dividends per share 2025 0.05 0.1 0.15

5.3 Sustainability

DPN/A
EPS Next 2Y33.36%
EPS Next 3Y29.48%
KMDA Yearly Income VS Free CF VS DividendKMDA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

More info and screens

Find the best dividend stocksShow peers with best dividend

KAMADA LTD

NASDAQ:KMDA (2/5/2026, 3:31:58 PM)

7.98

-0.12 (-1.48%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-10
Earnings (Next)03-03
Inst Owners11.42%
Inst Owner Change1%
Ins Owners2.34%
Ins Owner ChangeN/A
Market Cap460.29M
Revenue(TTM)174.79M
Net Income(TTM)20.45M
Analysts84.44
Price Target13.26 (66.17%)
Short Float %0.27%
Short Ratio1.02
Dividend
Industry RankSector Rank
Dividend Yield 2.4%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)20.52%
Min EPS beat(2)-4.61%
Max EPS beat(2)45.66%
EPS beat(4)3
Avg EPS beat(4)17.85%
Min EPS beat(4)-4.61%
Max EPS beat(4)45.66%
EPS beat(8)6
Avg EPS beat(8)19.32%
EPS beat(12)9
Avg EPS beat(12)7.95%
EPS beat(16)10
Avg EPS beat(16)-82.64%
Revenue beat(2)1
Avg Revenue beat(2)-0.44%
Min Revenue beat(2)-1.49%
Max Revenue beat(2)0.61%
Revenue beat(4)2
Avg Revenue beat(4)-0.44%
Min Revenue beat(4)-3.06%
Max Revenue beat(4)2.19%
Revenue beat(8)3
Avg Revenue beat(8)-0.6%
Revenue beat(12)4
Avg Revenue beat(12)-0.9%
Revenue beat(16)6
Avg Revenue beat(16)1.07%
PT rev (1m)0%
PT rev (3m)-18.75%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-22.5%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.92%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.28%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.27%
Valuation
Industry RankSector Rank
PE 22.17
Fwd PE 17.26
P/S 2.63
P/FCF 24.55
P/OCF 15.87
P/B 1.74
P/tB 1.96
EV/EBITDA 9.44
EPS(TTM)0.36
EY4.51%
EPS(NY)0.46
Fwd EY5.79%
FCF(TTM)0.33
FCFY4.07%
OCF(TTM)0.5
OCFY6.3%
SpS3.03
BVpS4.59
TBVpS4.07
PEG (NY)0.5
PEG (5Y)N/A
Graham Number6.1
Profitability
Industry RankSector Rank
ROA 5.42%
ROE 7.72%
ROCE 8.44%
ROIC 6.67%
ROICexc 8.54%
ROICexgc 9.66%
OM 15.89%
PM (TTM) 11.7%
GM 43.75%
FCFM 10.73%
ROA(3y)1.79%
ROA(5y)2.56%
ROE(3y)2.5%
ROE(5y)3.16%
ROIC(3y)2.97%
ROIC(5y)N/A
ROICexc(3y)3.77%
ROICexc(5y)N/A
ROICexgc(3y)8.9%
ROICexgc(5y)N/A
ROCE(3y)3.76%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-12.21%
ROICexc growth 3YN/A
ROICexc growth 5Y-24.77%
OM growth 3YN/A
OM growth 5Y-7.07%
PM growth 3YN/A
PM growth 5Y-13.08%
GM growth 3Y14.12%
GM growth 5Y2.16%
F-Score7
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.59
Debt/EBITDA 0.22
Cap/Depr 67.04%
Cap/Sales 5.86%
Interest Coverage 35.6
Cash Conversion 67.35%
Profit Quality 91.69%
Current Ratio 4.02
Quick Ratio 2.25
Altman-Z 3.62
F-Score7
WACC8.65%
ROIC/WACC0.77
Cap/Depr(3y)51.55%
Cap/Depr(5y)66.64%
Cap/Sales(3y)4.62%
Cap/Sales(5y)4.32%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)28.57%
EPS 3YN/A
EPS 5Y-13.6%
EPS Q2Q%28.57%
EPS Next Y44.17%
EPS Next 2Y33.36%
EPS Next 3Y29.48%
EPS Next 5YN/A
Revenue 1Y (TTM)10.36%
Revenue growth 3Y15.82%
Revenue growth 5Y4.82%
Sales Q2Q%12.63%
Revenue Next Year12.37%
Revenue Next 2Y11.88%
Revenue Next 3Y10.57%
Revenue Next 5YN/A
EBIT growth 1Y56.49%
EBIT growth 3YN/A
EBIT growth 5Y-2.59%
EBIT Next Year134.37%
EBIT Next 3Y44.92%
EBIT Next 5YN/A
FCF growth 1Y941.67%
FCF growth 3YN/A
FCF growth 5Y7.92%
OCF growth 1Y336.09%
OCF growth 3YN/A
OCF growth 5Y11.73%

KAMADA LTD / KMDA FAQ

Can you provide the ChartMill fundamental rating for KAMADA LTD?

ChartMill assigns a fundamental rating of 6 / 10 to KMDA.


What is the valuation status for KMDA stock?

ChartMill assigns a valuation rating of 7 / 10 to KAMADA LTD (KMDA). This can be considered as Undervalued.


Can you provide the profitability details for KAMADA LTD?

KAMADA LTD (KMDA) has a profitability rating of 7 / 10.


How financially healthy is KAMADA LTD?

The financial health rating of KAMADA LTD (KMDA) is 6 / 10.